Shed

Metrics show Shed posts starter prices on key product pages. GLP1 injections list a starting monthly price that includes medication, supplies, support, and free shipping. GLP1 lozenges show a separate starting price for users who prefer sublingual dosing. A newer oral liquid option lists a higher starting price than lozenges, which reflects compounding and format. Shed’s blog outlines that branded GLP1s begin at a higher monthly spend than compounded programs. Longevity pricing is specific as well. NAD+ shows a lower monthly starting price for nasal spray and a higher price for injections. Sermorelin has a clear monthly figure and dosing frequency per week. These list prices help shoppers estimate month one versus maintenance, but the exact dose and titration still shift total spend. Brand name acquisition may extend timelines and cost compared with compounded fills. The site emphasizes that compounded medications are prepared by licensed pharmacies when clinically appropriate, and brand availability can vary with supply. Overall, price clarity is strong at the entry point, with the main tradeoff emerging at higher doses and for brand products.

Analysis reveals a clear clinical framework. Product pages explain indications, common effects, and how dosing is administered while noting that compounded options are used only when a clinician deems them appropriate. Terms name multiple partner pharmacies, which improves transparency and allows patients to verify licensure. The same Terms document also explains that supply constraints can affect brand GLP1 availability and that some items may ship from outside the United States, which patients should weigh against preferences for domestic sourcing. Hair loss pages include safety notes around finasteride, including mental health and persistent side effect disclaimers, which is a positive risk communication practice. NAD+ pages list state exclusions for that therapy, signaling attention to state rules. We also saw a money back guarantee structure in the Terms with an effective date and eligibility rules, which sets expectations for those pursuing a weight target through the platform. Overall, Shed demonstrates appropriate clinical oversight, pharmacy disclosure, and safety messaging for higher risk categories, with room to add more prescriber credential details and monitoring cadence specifics in public copy.

Analysis reveals a fast digital intake. The journey described across product pages begins with a short online form and eligibility assessment by a licensed provider followed by shipment to the home. Shed indicates that compounded medications typically process within one to three business days with two to six days for delivery. The site also notes that some states may require a video consult after the intake, while others support an asynchronous review. Brand GLP1 fills can take longer than compounded equivalents. A separate blog guide frames a simple three step path from intake to delivery and sets typical arrival in five to ten business days after approval. These specifics help shoppers plan for first month timelines. The intake allows questions through the care team and sets expectations on dose commitment windows. Overall onboarding is efficient and mostly self directed, with a live visit requirement triggered by state rules. That flexibility supports a broad service footprint while keeping first shipment timelines predictable for most members.

Shed offers a broad menu inside our frozen list. For GLP1 & Weight Loss, members can pursue injections and a sublingual lozenge path within Semaglutide, and brand names are available where supply allows. The site also introduces oral liquid drops that use GLP1s in an oral format, which we track as a non canonical item. In Longevity, NAD+ is offered as injections with a separate nasal spray option listed outside the frozen set, and Sermorelin is presented as a nightly injection program. In Hair loss, Shed lists a two in one topical finasteride plus minoxidil solution and a five in one topical that still includes finasteride and minoxidil. There is also an oral three in one capsule with minoxidil and finasteride, which maps to Oral Minoxidil within our framework. Across therapies, choices are configured by the clinician and filled by named partner pharmacies. Dose bands and titration rules are not fully exposed on the public pages, which is common in this category, but entry formats and monthly baselines are clear.

Fulfillment windows are explicit. Help Center guidance states compounded medications typically process in one to three business days and then ship with two to six business days for delivery. Branded medications may take ten to fifteen business days. Multiple pages frame a consumer friendly expectation that medication arrives in about five to ten business days after approval, which matches our read of the processing and shipping math. Shed says it is available in all fifty states, though the NAD+ product page lists specific state exclusions for that therapy. Terms explain that prescriptions may be filled by a network of partner pharmacies and that some medications may ship from outside the United States, which some patients will want to confirm during consult. The balance of speed and disclosure is solid for compounded items and clear about potential slowdowns for brands. Tracking and carrier names are not listed in public copy. Refill timing and cold chain details for GLP1s are implied but not deeply documented on the site, which keeps this category just shy of a perfect score.

Support pathways include in portal messaging and email. A recent operations post sets expectations that the Care Team responds within twenty four to forty eight hours and that consecutive messages can extend wait times. The post also states the team will adjust billing dates if order processing delays occur, which is a helpful customer protection. The Terms list a support email and a physical address plus the Utah governing law venue for disputes, which gives consumers standard contact points and jurisdiction clarity. We did not see posted phone hours or real time chat, so urgent clinical needs should route through the platform’s medical channels rather than general support. Payment articles confirm that HSA and FSA cards are accepted for eligible prescription expenses with the usual administrator caveats. Overall, the support model fits a digital first clinic with stable asynchronous messaging, clear escalation channels, and predictable response windows, but it stops short of live real time coverage.

The site keeps navigation simple. Each therapy has a dedicated page with How it works and Pricing sections, which reduces surprise at checkout. The journey blocks repeat a three step path that begins with a quick eligibility form, followed by provider review, and then home delivery. A recent blog explains that pricing appears upfront in the portal and that payment plan options are visible. The Help Center shows straightforward account management steps to update billing and shipping, and the HSA FSA page clarifies which charges likely qualify. We found the experience consistent across GLP1, Longevity, and Hair categories with readable copy and clear CTAs. Areas for improvement include making consult requirements by state more explicit before checkout and summarizing cancellation cutoff dates where subscriptions apply. Even so, the combination of consistent templates, a simple portal flow, and visible starter pricing delivers a smooth self serve UX.